Abstract | AIM: METHODS: RESULTS: the inhibition of alveolarization was sustained in the LPS plus hyperoxia group from day 7 to 14, whereas alveolarization resumed in the hyperoxia group after oxygen exposure was withdrawn at day 7. Administration of LPS alone did not adversely affect lung morphometry. IL-6 levels showed transient overexpression at day 1 in the LPS-treated groups, but decreased at days 7 and 14. VEGF protein levels were elevated in the LPS-treated groups, but not in the hyper-oxia and control groups at days 1, 7, and 14. Exposure to hyperoxia affected protein carbonyl levels in the hyperoxia group at days 7 and 14. CONCLUSION:
|
Authors | Hyun Ju Lee, Chang Won Choi, Beyong Il Kim, Ee-Kyung Kim, Han-Suk Kim, Jung-Hwan Choi, Myong Jin Lee, Eun Gyeong Yang |
Journal | Journal of perinatal medicine
(J Perinat Med)
Vol. 38
Issue 6
Pg. 675-81
(11 2010)
ISSN: 1619-3997 [Electronic] Germany |
PMID | 20707615
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-6
- Lipopolysaccharides
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
|
Topics |
- Animals
- Animals, Newborn
- Bronchopulmonary Dysplasia
(chemically induced, metabolism, pathology)
- Disease Models, Animal
- Female
- Histocytochemistry
- Humans
- Hyperoxia
(pathology)
- Infant, Newborn
- Interleukin-6
(metabolism)
- Lipopolysaccharides
(pharmacology)
- Male
- Pregnancy
- Protein Carbonylation
- Pulmonary Alveoli
(drug effects, metabolism, ultrastructure)
- Rats
- Rats, Sprague-Dawley
- Survival Analysis
- Vascular Endothelial Growth Factor A
(metabolism)
|